Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > FOXO4-DRI for Sale > Hot Sale Wholesale Tirz/Sema/Reta Retatrutide Cagrilintide Nad+ Mt-II Peptides Betty
Hot Sale Wholesale  Tirz/Sema/Reta Retatrutide Cagrilintide Nad+ Mt-II Peptides Betty buy - large image1
Hot Sale Wholesale  Tirz/Sema/Reta Retatrutide Cagrilintide Nad+ Mt-II Peptides Betty buy - image1
Hot Sale Wholesale  Tirz/Sema/Reta Retatrutide Cagrilintide Nad+ Mt-II Peptides Betty buy - image2
Hot Sale Wholesale  Tirz/Sema/Reta Retatrutide Cagrilintide Nad+ Mt-II Peptides Betty buy - image3
Hot Sale Wholesale  Tirz/Sema/Reta Retatrutide Cagrilintide Nad+ Mt-II Peptides Betty buy - image4
Hot Sale Wholesale  Tirz/Sema/Reta Retatrutide Cagrilintide Nad+ Mt-II Peptides Betty buy - image5
Hot Sale Wholesale  Tirz/Sema/Reta Retatrutide Cagrilintide Nad+ Mt-II Peptides Betty buy - image6

Hot Sale Wholesale Tirz/Sema/Reta Retatrutide Cagrilintide Nad+ Mt-II Peptides Betty

28 Inquiries

Unit Price:

$5/UNIT FOB

Get Latest Price
CAS No.:

2460055-10-9

Grade:

ep

Content:

99.9%

Port:

HongKong

Packaging:

19-2 Vial

Price valid (until):

2026-11-05

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Tirzepatide,Retatrutide,NAD+,Samaglutide,GHK-CU,cagrilintide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    WhatsApp for more information.
    +852 9184 0124
    E-mail:bettyhuatai@hotmail.com




    Wholesale Price 5mg 10mg 15mg Retatrutide Weight Loss CAS: 2381089 83 2 

    Product Name Retatrutide
    Appearance White powder
    CAS No. 2381089-83-2
    Application Weight Loss
    Shelf Life  2 Years


      Product Detail  


     Why choose us? 


    1.Higher quality products (>=99% purity) for most of peptides and raws., adequate stock and fast delivery competitive price.

    2. Ship worldwide with safe and secure lines: 100% delivery guaranteed. No worry about Customs issues.

    3. Special Service: Drop-shipping if need.

    4. Cheapest prices in the market, unbeatable!

    5. Very reputable in the most famous boards such as Meso Rx forum and Professional muscle forums, with tons of positive reviews and blind lab tests done by our customers.

    6. Many payment options: PayPal, bank transfer, alipay,bitcoin

    7.Safe and fast delivery

    1)Parcel can be sent out in 2 working days after payment,tracking number available.

    2)Secure and discreet shipment,various transportation methods for your choice.

    3)Customs pass rate 99%
    Shop Hot Sale Wholesale  Tirz/Sema/Reta Retatrutide Cagrilintide Nad+ Mt-II Peptides Betty-Detailed Image 1
    Shop Hot Sale Wholesale  Tirz/Sema/Reta Retatrutide Cagrilintide Nad+ Mt-II Peptides Betty-Detailed Image 2
    Shop Hot Sale Wholesale  Tirz/Sema/Reta Retatrutide Cagrilintide Nad+ Mt-II Peptides Betty-Detailed Image 3
    Shop Hot Sale Wholesale  Tirz/Sema/Reta Retatrutide Cagrilintide Nad+ Mt-II Peptides Betty-Detailed Image 4
    Shop Hot Sale Wholesale  Tirz/Sema/Reta Retatrutide Cagrilintide Nad+ Mt-II Peptides Betty-Detailed Image 5
    ECHEMI Editorial Reference
    FOXO4-DRI (Retro-Inverso) is a synthetic, slightly modified version of the standard FOXO4 protein. The modification prolongs half-life of the protein and allows it to interfere with normal FOXO4 function. FOXO4-DRI has been shown in research to prevent normal FOXO4 binding to p53, thereby allowing for elimination of senescent cells, improved organ function, and younger tissue “biological age.” FOXO4-DRI impacts insulin signaling, cell cycle regulation, and oxidative stress signaling pathways. FOXO4-DRI is a cell penetrating peptide shown to selectively induce apoptosis of senescent cells thereby reversing effects of aging in animal studies.

    Basic Info
    Product Name:

    FOXO4-DRI

    Other Name:

    FOXO4-DRI;FOXO4 /FOXO4-DRI;FOX04-DRI (D-Retro-Inverso);Fox4-dri

    CAS No.:

    2460055-10-9

    Molecular Weight:

    0

    Color/Form:

    White to off-white

    Research
    Class:

    Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)

    Status:

    Investigational — Phase 3 (REDEFINE program, CagriSema combination)

    Mechanism:

    A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity. Administered once weekly.

    Activity note:

    Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.

    Source:

    MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.

    Clinical Development:

    NCT05249895; NCT05249882

    References
    PubChem:

    PubChem

    Disclaimer:

    Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Tirzepatide,Retatrutide,NAD+,Samaglutide,GHK-CU,cagrilintide

    Location:

    1502A1, Building 4, Xinyuanxin Center, No. 3 Huaxin Road, Dongfeng Street, Licheng District, Jinan City, Shandong Province

    Payment Terms:

    TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    1

    Total Annual Revenue:

    $10 million-$25 million

    Total Employees:

    51-100

    Year of Establishment:

    2026

    Certifications:

    COA,COA,COA,COA,COA,COA,COA,COA,COA,COA,COA,COA

    COMPANY INTRODUCTION

    20 years of dedicated work in the peptide industry

    15 Years of Industry Experience

    We have been a high-tech company focused on the development, production, and marketing of various peptide products

     for 15 years. Through advanced laboratories and strict quality control, our internationally certified products are safe and 

    effective.


    Clients in Europe, the USA, Southeast Asia, and the Middle East

    As a global trading company, we serve clients across Europe, the USA, Southeast Asia, the Middle East, and beyond, providing

     customized solutions. Committed to "technology leading Health", we aim to innovate and deliver high-quality health products 

    worldwide.


    3,000sqm Factory with 60 Employees

    We have a factory covering 3,000 square meters and housing 60 employees to guarantee the highest quality all the time. We hired 

    three quality auditors with three years of experience. They meticulously inspect each item at every production stage.


    Contact Us Now

    Our products are exported to more than 130 countries and regions, which can be delivered fast within 5-14 days. We can provide

     OEM/ODM support to our customers. We have 10 professional after-sales staff to make 24-hour responses to our customers. 

    Contact us now to learn more. We hope to establish stable and strategic long-term business relationships with domestic and 

    foreign suppliers and customers, jointly pursuing a better future.


  • Inquiry History
    28 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    FOXO4-DRI

    1 G Dec 3, 2023
    Germany

    foxo4-dri

    1 G Aug 23, 2026
    United States

    Fox04-dri

    1 G May 20, 2026
    United States

    hot-sale-high-purity-raw-powder-fox04-dri-nad-ghk-cu-mot

    2 PCS Dec 19, 2025
    United States

    foxo4 dri

    10 MT Dec 13, 2025
    United States

    Fox04

    10 MG Oct 30, 2024
    Norway

    FOXO4-DRI

    200 MG Sep 3, 2026
    United Kingdom

    High purity foxo4

    1 G May 31, 2026
    United Kingdom

    Foxo4-Dri

    10 MG May 5, 2026
    United States

    Fox04-dri

    100 MG Apr 28, 2026
    Cyprus

    Foxo4 dri

    10 MT Apr 4, 2026
    Cyprus

    FOXO4-DRI

    1 KG Feb 2, 2026
    United States

    FOX04-DRI

    10 PCS Jan 12, 2026
    United States

    FOX04

    10 PCS Jan 12, 2026
    United States

    Foxo4 Dri

    40 MG Sep 15, 2025
    United States

    Fox04 dri

    10 MT Jun 21, 2026
    United States

    FOX04-DRI powder

    10 MT May 29, 2026
    United States

    fox04

    1 G Apr 29, 2026
    United States

    FOXO4-DRI

    1 KG Mar 23, 2026
    United States

    Foxo4-Dri

    Nov 24, 2025
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.